A surface engineering approach for silicone elastomers that reduces friction without oils, softeners, coatings, or additives. By combining mold-defined surface morphology with depth-controlled UV-ozone conversion, the method sets friction mechanically and eliminates migration-driven drift, targeting stable low-friction performance in consumer and industrial applications.
This technology reduces the coefficient of friction (CoF) of silicone elastomers without changing the material composition or adding any low-molecular-weight species. Friction is set mechanically by imposing a defined surface morphology directly from the mold and then converting the outermost layer with a controlled UV-ozone (UVO) treatment. Because no oil, softener, coating, or additive is introduced, there are no mobile species that can migrate to the surface over time, preventing the drift in surface properties often seen in conventionally modified silicones.
The approach targets a CoF of 0.4–0.6 with surface stiffness in the 10–100 kPa range, using a commercially available low-extractables silicone as the base material. Applications include seals, gaskets, elastomeric grips, medical device surfaces, and other silicone components where long-term, stable low friction is required without bleed-out or contamination.
How it works:
Key features:
The technology is in the research and validation stage. Planned work includes selecting a commercial low-extractables silicone with appropriate bulk shear modulus and elasticity ratio, generating designed mold textures, mapping UV-ozone dose to converted-layer depth and surface energy, measuring friction under continuous shear, and verifying performance under accelerated aging. The integrated surface design has not yet been demonstrated on a finished product, but it builds on established physics and mature manufacturing steps, so the path to practical implementation is clearly defined.
Northwestern University is a comprehensive private research university with campuses in Evanston and downtown Chicago and a collaborative, cross‑disciplinary culture. Integration with a major hospital system enables clinical research, diverse patient access, and rapid translation from bench to bedside. Shared research cores, prototyping facilities, a campus incubator, and dedicated corporate engagement teams make it straightforward to scope projects, structure agreements, and place talent. Research is supported by competitive federal funding from agencies such as NIH, NSF, DOE, and DoD, complemented by foundation and industry partnerships. A dedicated technology transfer office advances IP strategy, licensing, and startup formation.